Pulmonary hypertension in children and adolescents with sickle cell disease.
about
The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.Strategic plan for pediatric respiratory diseases research: an NHLBI working group report.Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.Polysomnographic characteristics of a referred sample of children with sickle cell disease.Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathVasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsProspective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.Pleiotropic effects of intravascular haemolysis on vascular homeostasis.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersUpper airway lymphoid tissue size in children with sickle cell diseasePrevalence of pulmonary arterial hypertension among sickle cell disease patients in Al Hassa.Cardiovascular abnormalities in sickle cell disease.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.Pulmonary hypertension in children with sickle cell disease.Towards improving the care of children with pulmonary hypertension: The rationale for developing a Pediatric Pulmonary Hypertension Network.Intravascular hemolysis and the pathophysiology of sickle cell disease.An association between pulmonary hypertension and impaired lung function in infants with congenital diaphragmatic hernia.A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia.Vascular risk assessment in patients with sickle cell disease.N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity.Airway inflammation in sickle cell disease-A translational perspective.Sleep pathology characterization in sickle cell disease: case-control study.A modified noninvasive screening protocol for pulmonary hypertension in children with sickle cell disease-Who should be sent for invasive evaluation?
P2860
Q30250302-7FD25C7B-2C91-443C-B9C5-BC17D9BE1CF9Q30485294-717CFEBF-6C13-49B9-9471-13D25685BBCEQ33690218-E552CD4F-F66B-4D3A-8605-9C21C2B52541Q33803027-4AD4FB88-04C3-46D6-BD2F-00358C8F1F3DQ33899415-E1347581-DC59-4393-9D3F-8D6D5639EFB5Q33997200-7205FD14-C5CD-4F19-B13B-386CDD7F1192Q34058187-96CDB799-2C85-4618-A20A-67684C318F3BQ34111548-8BCF2AB7-2626-4D15-B7EA-3320EF655A13Q34992760-E9DD9D0C-A8F4-489E-9AC1-C9310BFD21A0Q35399728-BEEE68F5-FEDE-46F5-9130-954326651E4CQ35508045-7311E188-5A72-4859-A88B-0AD9CC17E92DQ35535204-0A38BE2E-C055-4739-B6EA-FC382FF6F320Q35590733-DBD3345B-4DED-4418-AF75-2A00DA4345F3Q36165026-9D8B2367-79DC-4CF9-AD33-E57E964FE20FQ36647856-D0AA30CD-E0E9-41AC-9D6F-D17B2A4FA7F5Q37435068-3795A913-420F-4921-AD01-C92184BE5ADBQ37565002-4016A796-2BDB-480D-962C-522B96836749Q37867674-BA66F6FE-E8C2-40E4-850C-99F368BD5B43Q38433348-E706DCAA-377F-45BD-8D70-E4BA2088529DQ39156028-E4A1F432-92C2-4800-AAF0-D574EF740D44Q39232600-B99D4FDA-26DA-4A24-B692-DD570247D42DQ39269713-7ADDE33F-856E-483E-9E7F-7A108316D2EEQ42558427-64A700C8-2F44-4CB7-98B3-EB8BE36EF6ECQ43180474-48AFBD37-47B7-424A-8613-884A7B6EA45DQ46344026-60A37151-D2E2-4468-8115-C6320B941AA2Q46507101-22574CC5-DD89-42CB-82A6-FFCD1856F6CAQ47647345-A39FBCCF-1603-4C1C-9671-AA449F95E03BQ48092704-EDC71D3E-7F48-48BC-90C4-A967E1170E80Q52772793-EFA5A2E5-73D7-4D07-A904-846F4643E855
P2860
Pulmonary hypertension in children and adolescents with sickle cell disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pulmonary hypertension in children and adolescents with sickle cell disease.
@en
Pulmonary hypertension in children and adolescents with sickle cell disease.
@nl
type
label
Pulmonary hypertension in children and adolescents with sickle cell disease.
@en
Pulmonary hypertension in children and adolescents with sickle cell disease.
@nl
prefLabel
Pulmonary hypertension in children and adolescents with sickle cell disease.
@en
Pulmonary hypertension in children and adolescents with sickle cell disease.
@nl
P2093
P1433
P1476
Pulmonary hypertension in children and adolescents with sickle cell disease.
@en
P2093
A Akintilo
A Campbell
J Williams
O C Onyekwere
P2888
P304
P356
10.1007/S00246-007-9018-X
P577
2007-08-07T00:00:00Z